Regulation of antibody immunotherapy by fine-tuning FcR interactions

Video   Apr 22, 2013

 

About the Speaker


Mark Cragg is a Professor in Experimental Cancer Biology at the Cancer Sciences Division of Southampton University School of Medicine, UK. He obtained his PhD in 1998 and did his postdoctoral studies with Martin Glennie in Southampton and then Andreas Strasser at the Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. He has published over 60 papers, many in high impact journals such as the Journal of Clinical Investigation, PNAS, Plos Medicine and Blood and leads a dynamic research group interested in all aspects of how therapeutics such as antibodies result in tumour regression and how they can be improved.
Abstract

Monoclonal antibodies (mAb) represent a growing class of ‘block-buster’ cancer drugs and so understanding of their modes of action is critical. Here, we present evidence that different mAb interact with Fc receptors differently in order to achieve their therapeutic activities.

 
 
 
 

Recommended Videos

Zika Virus: Researchers Develop New Model to Help Test Vaccines and Treatments

Video

An alternative animal model that mimics key features of the Zika virus infection, including its lingering presence in bodily fluids, has been developed at Texas Biomedical Research Institute in San Antonio, to help develop vaccines and treatments.

WATCH NOW

Immunotherapy: Cancer Assassin

Video

Research at the University of Southampton is looking at how immunotherapy can enable the body’s immune system to recognise and kill cancer cells.

WATCH NOW

Curing Cancer With Our Immune System

Video

Professor Peter Johnson - Professor of Medical Oncology, University of Southampton and Chief Clinician for Cancer Research UK.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE